ASCL1 and small cell lung carcinoma: Studies have demonstrated that MYCL is amplified or highly expressed in the SCLC-A subtype and plays a pivotal role in ASCL1 function, while other subtypes tend to display MYC amplification or overexpression, suggesting that MYC predominates in SCLC with low NE status (13, 69).